Inhibiting HDACs restores the acetylation of histone and increases the expression of the p21 gene, highlighting that increased HDAC activity underlies the deficient histone acetylation seen in prostate cancer (40). This evidence concerns the gene HDAC9 and Familial prostate cancer.